@haidut You mentioned that doses up to 2mg will tend to lower prolactin, but that doses > 2 or 4mg can raise prolactin due to dopamine antagonism. Many people have repeated this claim in several threads, but so far I have never seen any study demonstrating that, and as far as I can see you haven't cited anything, either. Do you know of any study/trial where they actually reported raised prolactin?
The studies in the thread you linked to show prolactin levels in response to TRH injection. Basal levels were lowered by cyproheptadine, and in hyperprolactinemia even very large doses of cypro lower prolactin very drastically. Even metergoline does not prevent a prolactine increase after TRH stimulation.
J Reprod Med. 1987 Feb;32(2):115-9.
Metergoline as an inhibitor of prolactin release.
Caballero A Sr, Mena P, Caballero-Díaz JL, Caballero-Asensi A.
Abstract
In a randomized, double-blind study, 12 and 16 mg of metergoline and 5 mg of bromoergocriptine were given daily to three groups of 100 women each for ten consecutive days to prevent lactation. Excellent or good results were obtained in 86%, 90% and 83%, respectively. Serum prolactin (PRL) levels were evaluated in three settings. The first was after a single dose in four groups of patients (4, 6 and 8 mg of metergoline and 2.5 mg of bromoergocriptine were studied for ten hours). Second, for a study of the suckling reflex, PRL levels were measured 15, 30 and 60 minutes after breast stimulation in four groups of five patients each: two groups on the fourth postpartum day with and without metergoline treatment and two groups on the eighth postpartum day (the reflex was suppressed in the two groups treated with metergoline). Third, serum PRL levels rose after the intravenous administration of 200 mg of thyrotropin-releasing hormone (TRH) in another two groups of ten patients, one treated with metergoline and the other not so treated. TRH stimulation was not blocked in the treated groups.
Here is one. Yes, the animals had prolactinoma but it is an in vivo study and other dopaminergic chemicals like bromoriptine reliably lower PRL in humans or animals with such condition.
Effects of Cyproheptadine on Prolactin Synthesis and Release by Normal and Suppressed Pituitary Glands and by Dispersed Pituitary Tumor Cells *
"..Chronic administration of cyproheptadine to rats bearing a transplantable PRL-secreting pituitary tumor, however, had a stimulating effect on the PRL synthesis and release by the suppressed, atrophied pituitary glands of these animals. In addition, methysergide administration also increased the radioimmunoassayable PRL content of the pituitary gland and additionally stimulated the growth of atrophied pituitary gland in tumor-bearing rats."
In addition, cypro enhanced the TRH-stimulated prolactin release. This is different than simply not being able to block it and as you cans even the authors of that study refer to cypro's anti-dopaminergic effects as an explanation.
Augmentation of prolactin response to TRH after cyproheptadine
"...Serum PRL, TSH, T3 and T4 were estimated in the basal state and following iv bolus injection of 100 μg synthetic thyrotropin releasing hormone before and 7 days after cyproheptadine treatment in 5 healthy adult males. Only the PRL response to TRH was augmented after cyproheptadine. This is perhaps related to the antidopaminergic effect of cyproheptadine."
Given that cyproheptadine's dopamine blocking effects have been confirmed and the affinity for D receptors is more or less known, I'd use the minimum dose that blocks serotonin receptors but does not affect the dopamine ones. I think this is also a reason Peat never recommends more than 4mg cypro daily and usually caps it at 2mg even for people with cancer.